These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 21076448)
21. The use of bisphosphonates in cancer patients. Wu S; Dahut WL; Gulley JL Acta Oncol; 2007; 46(5):581-91. PubMed ID: 17562434 [TBL] [Abstract][Full Text] [Related]
22. [Kidney and bone update : the 5-year history and future of CKD-MBD. Bisphosphonates treatment for chronic kidney disease-mineral and bone disorder]. Mori H; Okada Y; Tanaka Y; Hashimoto O Clin Calcium; 2012 Jul; 22(7):1034-42. PubMed ID: 22750936 [TBL] [Abstract][Full Text] [Related]
29. Persistence with bisphosphonate therapy in older people. Melo M; Qiu F; Sykora K; Juurlink D; Laupacis A; Mamdani M J Am Geriatr Soc; 2006 Jun; 54(6):1015-6. PubMed ID: 16776810 [No Abstract] [Full Text] [Related]
30. Can the bisphosphonate I'm taking for osteoporosis actually cause a bone fracture? Johns Hopkins Med Lett Health After 50; 2011 Oct; 23(8):7. PubMed ID: 22059260 [No Abstract] [Full Text] [Related]
32. Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue. Toussaint ND; Elder GJ; Kerr PG Clin J Am Soc Nephrol; 2009 Jan; 4(1):221-33. PubMed ID: 18987295 [TBL] [Abstract][Full Text] [Related]
33. A once-yearly IV bisphosphonate for osteoporosis. Med Lett Drugs Ther; 2007 Nov; 49(1273):89-90. PubMed ID: 17975523 [No Abstract] [Full Text] [Related]
35. [Clinical implications of bisphosphonate for bone metastases of prostate cancer]. Kitagawa Y; Konaka H; Mizokami A; Namiki M Nihon Rinsho; 2007 Nov; 65 Suppl 9():356-9. PubMed ID: 18161131 [No Abstract] [Full Text] [Related]
36. Who will benefit from antiresorptive treatment (bisphosphonates)? Papapoulos SE Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):965-73. PubMed ID: 16301190 [TBL] [Abstract][Full Text] [Related]
38. [Glucocorticoid and Bone. Efficacy and safety of bisphosphonate in treatment of glucocorticoid induced osteoporosis]. Tanaka I Clin Calcium; 2014 Sep; 24(9):1371-8. PubMed ID: 25177010 [TBL] [Abstract][Full Text] [Related]
39. Bisphosphonates in the treatment of metabolic bone diseases. Arantes HP; Silva AG; Lazaretti-Castro M Arq Bras Endocrinol Metabol; 2010 Mar; 54(2):206-12. PubMed ID: 20485910 [TBL] [Abstract][Full Text] [Related]
40. Drug treatment for low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians. Ann Intern Med; 2008 Sep; 149(6):I46. PubMed ID: 18794555 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]